Reoxygenation during radiotherapy in intermediate-risk prostate cancer.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 30935573.
- Also identified by DOI 10.1016/j.radonc.2018.12.022.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hypoxia is a major risk factor of prostate cancer radioresistance. We evaluated hypoxia non-invasively, using <sup>18</sup>F-Misonidazole PET/CT prior to radiotherapy and after a dose of 20 Gy in intermediate-risk prostate cancer patients. Decreased hypoxic volumes were observed in all patients, suggesting that radiotherapy induces early prostate tumor reoxygenation.
Medical subject headings
- Cell Hypoxia
- Prostatic Neoplasms